Although LDHA inhibition has not been previously examined, LDHA knockout NSCLC models have decreased tumor formation and even show regression of stablished tumors (142), providing evidence that LDHA may be a future viable target for lung cancer therapies. The gene discussed is LDHA; the disease is lung cancer.